Nitta, Kosaku
Kuragano, Takahiro
Joki, Nobuhiko
Tsuruya, Kazuhiko
Honda, Hirokazu
Hamano, Takayuki
Fujii, Hideki
Uemura, Yukari
Tsuchiya, Ken
,
Ohashi, Yasuo
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
https://doi.org/10.1186/s41100-022-00450-3
Funding for this research was provided by:
Chugai Pharmaceutical
Article History
Received: 22 July 2022
Accepted: 20 November 2022
First Online: 16 December 2022
Declarations
:
: The protocol was approved by the Non-Profit Organization MINS Institutional Review Board (approval no. 130201). Written informed consent to participate in this study was obtained from all patients.
: Not applicable.
: KN has received speakers fee as honoraria from Chugai and Kyowa Kirin, and grants from Chugai and Kyowa Kirin. KTsuchiya has received speakers fee as honoraria from Chugai, Kyowa Kirin, Otsuka, Ono, and Bayer, grants from Chugai, Kyowa Kirin, Otsuka, Ono, Kissei, Baxter, and Tanabe Mitsubishi, and fees for advisory board as honoraria from Chugai, Kissei, and Sanwa. TK has received speakers fee as honoraria from Chugai and Kyowa Kirin. NJ has received speakers fee as honoraria from Chugai, Kyowa Kirin, and Torii, and grants from Chugai, Kyowa Kirin, and Torii. KTsuruya has received speakers fee as honoraria from Chugai, Kyowa Kirin, and Kissei, and grants from Chugai and Kyowa Kirin. H. Honda has received speakers fee as honoraria from Chugai, Kissei, Torii, Tanabe Mitsubishi, and Astellas. TH has received speakers fee as honoraria from Chugai, Kyowa Kirin, Kissei, Ono, Torii, Otsuka, Bayer, Asahi Kasei, and Astellas, grants from Chugai, Kyowa Kirin, Kissei, Ono, Torii, Otsuka, Terumo, Fuso, Bayer, Asahi Kasei, Eisai, and Takeda, and fees for advisory board as honoraria from Kyowa Kirin, Ono, Glaxo Smithkline, and Astellas. HF has received speakers fee as honoraria from Chugai and Kyowa Kirin, fees for advisory board as honoraria from Chugai, and scholarship grants from Chugai and Kyowa Kirin. YU has received speakers fee as honoraria from Chugai. TK and KT are the Associate Editors of Renal Replacement Therapy.